Leap Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Leap Therapeutics's estimated annual revenue is currently $10.4M per year.(i)
  • Leap Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Leap Therapeutics has 67 Employees.(i)
  • Leap Therapeutics grew their employee count by 49% last year.

Leap Therapeutics's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
President & CEOReveal Email/Phone
3
CEOReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
Chief Manufacturing OfficerReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
VP, Program LeadershipReveal Email/Phone
9
VP, Biomedical Operations and Head BiometricsReveal Email/Phone
10
VP, Regulatory Affairs & QualityReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Leap Therapeutics?

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.

keywords:N/A

N/A

Total Funding

67

Number of Employees

$10.4M

Revenue (est)

49%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.3M675%N/A
#2
$8.5M67-12%$55.9M
#3
$5.2M67-68%$377.5M
#4
$17.5M676%N/A
#5
$9M6722%N/A